Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 53

2.

Defining high, medium and low impact prognostic factors for developing multiple sclerosis.

Tintore M, Rovira À, Río J, Otero-Romero S, Arrambide G, Tur C, Comabella M, Nos C, Arévalo MJ, Negrotto L, Galán I, Vidal-Jordana A, Castilló J, Palavra F, Simon E, Mitjana R, Auger C, Sastre-Garriga J, Montalban X.

Brain. 2015 Jul;138(Pt 7):1863-74. doi: 10.1093/brain/awv105. Epub 2015 Apr 21.

PMID:
25902415
3.

PLAY Project Home Consultation intervention program for young children with autism spectrum disorders: a randomized controlled trial.

Solomon R, Van Egeren LA, Mahoney G, Quon Huber MS, Zimmerman P.

J Dev Behav Pediatr. 2014 Oct;35(8):475-85. doi: 10.1097/DBP.0000000000000096.

4.

[Aspects of quality of life of residents of a nursing oasis from the perspectives of relatives and nurses- qualitative results of an evaluation study].

Brandenburg H, Adam-Paffrath R, Güther H.

Pflege. 2014 Apr;27(2):69-80. doi: 10.1024/1012-5302/a000347. German.

PMID:
24670540
5.

Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients.

Río J, Rovira A, Tintoré M, Sastre-Garriga J, Castilló J, Auger C, Nos C, Comabella M, Tur C, Vidal Á, Montalbán X.

Mult Scler. 2014 Oct;20(12):1602-8. doi: 10.1177/1352458514527863. Epub 2014 Mar 12.

PMID:
24622350
6.

Prognostic factors of neurocognitive and functional outcomes in junior and senior elderly patients with traumatic brain injury undergoing disability evaluation or appointed disability evaluation.

Jung YJ, Kim OL, Kim MS, Cheon EJ, Bai DS.

J Korean Neurosurg Soc. 2014 Jan;55(1):18-25. doi: 10.3340/jkns.2014.55.1.18. Epub 2014 Jan 31.

7.

A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.

Ramo-Tello C, Grau-López L, Tintoré M, Rovira A, Ramió i Torrenta L, Brieva L, Cano A, Carmona O, Saiz A, Torres F, Giner P, Nos C, Massuet A, Montalbán X, Martínez-Cáceres E, Costa J.

Mult Scler. 2014 May;20(6):717-25. doi: 10.1177/1352458513508835. Epub 2013 Oct 21.

PMID:
24144876
8.

No sex differences in neuropsychological performance in first episode psychosis patients.

Ayesa-Arriola R, Rodriguez-Sanchez JM, Gomez-Ruiz E, Roiz-Santiáñez R, Reeves LL, Crespo-Facorro B.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:149-54. doi: 10.1016/j.pnpbp.2013.09.009. Epub 2013 Sep 25.

PMID:
24075821
9.

Neurological outcome scale for traumatic brain injury: III. Criterion-related validity and sensitivity to change in the NABIS hypothermia-II clinical trial.

McCauley SR, Wilde EA, Moretti P, Macleod MC, Pedroza C, Drever P, Fourwinds S, Frisby ML, Beers SR, Scott JN, Hunter JV, Traipe E, Valadka AB, Okonkwo DO, Zygun DA, Puccio AM, Clifton GL.

J Neurotrauma. 2013 Sep 1;30(17):1506-11. doi: 10.1089/neu.2013.2925. Epub 2013 Aug 2.

10.

Common polymorphisms in nitric oxide synthase (NOS) genes influence quality of aging and longevity in humans.

Montesanto A, Crocco P, Tallaro F, Pisani F, Mazzei B, Mari V, Corsonello A, Lattanzio F, Passarino G, Rose G.

Biogerontology. 2013 Apr;14(2):177-86. doi: 10.1007/s10522-013-9421-z. Epub 2013 Apr 10.

PMID:
23572278
11.

Occupational outcome in bipolar disorder is not predicted by premorbid functioning and intelligence.

Schoeyen HK, Melle I, Sundet K, Aminoff SR, Hellvin T, Auestad BH, Morken G, Andreassen OA.

Bipolar Disord. 2013 May;15(3):294-305. doi: 10.1111/bdi.12056. Epub 2013 Mar 26.

PMID:
23527993
12.

Psychiatric symptoms of patients with primary mitochondrial DNA disorders.

Inczedy-Farkas G, Remenyi V, Gal A, Varga Z, Balla P, Udvardy-Meszaros A, Bereznai B, Molnar MJ.

Behav Brain Funct. 2012 Feb 13;8:9. doi: 10.1186/1744-9081-8-9.

13.

Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.

Tur C, Montalban X, Tintoré M, Nos C, Río J, Aymerich FX, Brieva L, Téllez N, Perkal H, Comabella M, Galán I, Calle D, Sastre-Garriga J, Rovira A.

Arch Neurol. 2011 Nov;68(11):1421-7. doi: 10.1001/archneurol.2011.241.

PMID:
22084124
14.

The relationship between self-rated disability, fear-avoidance beliefs, and nonorganic signs in patients with chronic whiplash-associated disorder.

Vernon H, Guerriero R, Soave D, Kavanaugh S, Puhl A, Reinhart C.

J Manipulative Physiol Ther. 2011 Oct;34(8):506-13. doi: 10.1016/j.jmpt.2011.08.011.

PMID:
21978543
15.

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.

Freedman MS, Bar-Or A, Oger J, Traboulsee A, Patry D, Young C, Olsson T, Li D, Hartung HP, Krantz M, Ferenczi L, Verco T; MAESTRO-01 Investigators.

Neurology. 2011 Oct 18;77(16):1551-60. doi: 10.1212/WNL.0b013e318233b240. Epub 2011 Oct 5.

PMID:
21975206
16.

Is long-term prognosis for pervasive developmental disorder not otherwise specified different from prognosis for autistic disorder? Findings from a 30-year follow-up study.

Mordre M, Groholt B, Knudsen AK, Sponheim E, Mykletun A, Myhre AM.

J Autism Dev Disord. 2012 Jun;42(6):920-8. doi: 10.1007/s10803-011-1319-5.

17.

Despite clinical differences, bipolar disorder patients from acute wards and outpatient clinics have similar educational and disability levels compared to the general population.

Schoeyen HK, Vaaler AE, Auestad BH, Malt UF, Melle I, Andreassen OA, Morken G.

J Affect Disord. 2011 Jul;132(1-2):209-15. doi: 10.1016/j.jad.2011.02.025. Epub 2011 Mar 25.

PMID:
21440307
18.

An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosis.

Horga A, Castillo J, Rio J, Tintore M, Auger C, Sastre-Garriga J, Edo MC, Perez-Miralles F, Tur C, Nos C, Huerga E, Comabella M, Rovira A, Montalban X.

Rev Neurol. 2011 Mar 16;52(6):321-30. English, Spanish.

19.

Bipolar disorder patients have similar levels of education but lower socio-economic status than the general population.

Schoeyen HK, Birkenaes AB, Vaaler AE, Auestad BH, Malt UF, Andreassen OA, Morken G.

J Affect Disord. 2011 Mar;129(1-3):68-74. doi: 10.1016/j.jad.2010.08.012. Epub 2010 Sep 15.

PMID:
20832866
20.

The Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI): II. Reliability and convergent validity.

McCauley SR, Wilde EA, Kelly TM, Weyand AM, Yallampalli R, Waldron EJ, Pedroza C, Schnelle KP, Boake C, Levin HS, Moretti P.

J Neurotrauma. 2010 Jun;27(6):991-7. doi: 10.1089/neu.2009.1195.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk